Jean‐Michel Pignon
- Hematology top 2%
- Genetics top 5%
- Rheumatology top 5%
- Immunology
- Molecular Biology
- Co-authors
- Michel TulliezH RochantWilliam VainchenkerHélène JouaultStéphane GiraudierJoëlle GuilhotLaurence LegrosPhilippe Rousselot
- Topics
- Chronic Myeloid Leukemia Treatments (6 papers)Acute Myeloid Leukemia Research (4 papers)Chronic Lymphocytic Leukemia Research (4 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- FranceSwitzerland
In The Last Decade
Jean‐Michel Pignon
14 papers receiving 558 citations
Peers
Comparison fields: 5 of 57
- Hematology 417
- Genetics 282
- Rheumatology 224
- Immunology 130
- Molecular Biology 71
Countries citing papers authored by Jean‐Michel Pignon
This map shows the geographic impact of Jean‐Michel Pignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Pignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Pignon more than expected).
Fields of papers citing papers by Jean‐Michel Pignon
This network shows the impact of papers produced by Jean‐Michel Pignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Pignon. The network helps show where Jean‐Michel Pignon may publish in the future.
Co-authorship network of co-authors of Jean‐Michel Pignon
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Michel Pignon. A scholar is included among the top collaborators of Jean‐Michel Pignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Michel Pignon. Jean‐Michel Pignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 12 | |
| 3 | 230 | |
| 4 | 2 | |
| 5 | 34 | |
| 6 | [Bcr-abl translocation: diagnostic methods and clinical value]. | 1 |
| 7 | 126 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 22 | |
| 12 | 1 | |
| 13 | 44 | |
| 14 | 4 | |
| 15 | Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. | 70 |
About Jean‐Michel Pignon
Jean‐Michel Pignon is a scholar working on Hematology, Genetics and Rheumatology, having authored 15 papers that have together received 575 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (417 citations), Genetics (282 citations) and Rheumatology (224 citations). Jean‐Michel Pignon has collaborated with scholars based in France and Switzerland. Frequent co-authors include Michel Tulliez, H Rochant, William Vainchenker, Hélène Jouault, Stéphane Giraudier, Joëlle Guilhot, Laurence Legros, Philippe Rousselot, Bruno Villemagne and Gabriel Étienne. Their work appears in journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.